
Am J Psychiatry 157:1134-1140, July 2000
© 2000 American Psychiatric Association
Elevated Central Serotonin Transporter Binding Availability in Acutely Abstinent Cocaine-Dependent Patients
Leslie K. Jacobsen, , M.D.,
Julie K. Staley, , Ph.D.,
Robert T. Malison, , M.D.,
Sami S. Zoghbi, , Ph.D.,
John P. Seibyl, , M.D.,
Thomas R. Kosten, , M.D., and
Robert B. Innis, , M.D., Ph.D.
OBJECTIVE: Recent work has underscored the role of serotonergic neurotransmission in chronic neural adaptations to cocaine dependence. The authors tested for evidence of serotonergic dysfunction during acute abstinence from cocaine, a period of high risk for relapse in cocaine dependence.METHOD: Binding availability of dopamine transporters and serotonin transporters was measured in 15 cocaine-dependent subjects during acute abstinence and in 37 healthy comparison subjects by using [123I]ß-CIT and single photon emission computed tomography.RESULTS: Significant increases in diencephalic and brainstem serotonin transporter binding (16.7% and 31.6%, respectively) were observed in cocaine-dependent subjects. Brainstem serotonin transporter binding was significantly inversely correlated with age across diagnostic groups.CONCLUSIONS: These findings provide further evidence of serotonergic dysfunction during acute abstinence from chronic cocaine use. Age-related decline in brainstem serotonin transporter binding may underlie the poor response to selective serotonin reuptake inhibitor antidepressants seen in some elderly depressed patients.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Sekine, Y. Ouchi, N. Takei, E. Yoshikawa, K. Nakamura, M. Futatsubashi, H. Okada, Y. Minabe, K. Suzuki, Y. Iwata, et al.
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Arch Gen Psychiatry,
January 1, 2006;
63(1):
90 - 100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen
Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Pharmacol. Rev.,
March 1, 2005;
57(1):
1 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Buchert, R. Thomasius, F. Wilke, K. Petersen, B. Nebeling, J. Obrocki, O. Schulze, U. Schmidt, and M. Clausen
A Voxel-Based PET Investigation of the Long-Term Effects of "Ecstasy" Consumption on Brain Serotonin Transporters
Am J Psychiatry,
July 1, 2004;
161(7):
1181 - 1189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Buchert, R. Thomasius, B. Nebeling, K. Petersen, J. Obrocki, L. Jenicke, F. Wilke, L. Wartberg, P. Zapletalova, and M. Clausen
Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET
J. Nucl. Med.,
March 1, 2003;
44(3):
375 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. McMahon, M. Filip, and K. A. Cunningham
Differential Regulation of the Mesoaccumbens Circuit by Serotonin 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors
J. Neurosci.,
October 1, 2001;
21(19):
7781 - 7787.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|